Put companies on watchlist
Warimpex Finanz- und Beteiligungs AG
ISIN: AT0000827209
WKN: A0LGV4
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Warimpex Finanz- und Beteiligungs AG · ISIN: AT0000827209 · EQS - Analysts (5 News)
Country: Germany · Primary market: Austria · EQS NID: 19983
06 June 2024 06:41AM


Original-Research: Warimpex Finanz- und Beteiligungs AG - from East Value Research GmbH

Classification of East Value Research GmbH to Warimpex Finanz- und Beteiligungs AG

Company Name: Warimpex Finanz- und Beteiligungs AG ISIN: AT0000827209

Reason for the research: Update
from: 06.06.2024
Target price: EUR 1.58
Target price on sight of: 12-Monaten
Last rating change:
Analyst: Adrian Kowollik

Despite strong Hotel business, where the average occupancy rate is developing well, Warimpex’ (WXF) Q1/24 results were weak. The reason was a 9.3% decline in the Investment properties segment, which we believe stemmed from two factors that will likely persist in Q2-Q4 2024: 1. A weak rouble FX rate, and 2. Increasing problems with Russian tenants such as Gazprom that seek to reduce office space and rent. As we wrote in previous reports on WXF, Russia – which still accounts for >60% of the company’s total turnover and 35% of its Gross Asset Value – is the biggest risk from investors’ perspective and the reason for the high discount to NAV. Based on our lower estimates for 2024E-2026E and lower peer-group-based fair value (EUR 1.44 vs. EUR 2.66 before), we have determined a new 12-months PT (50% NNNAV that we have additionally discounted by 50% due to the exposure to Russia, 50% peer group) for Warimpex of EUR 1.58 (previously: EUR 2.23).

In Q1/24, the main factors affecting Warimpex’ results included: 1. Higher occupancy rates in the Hotels segment 2. Weaker Russian rouble 3. Higher operating costs and 4. Provisions for trade receivables, in our view relating to Russian clients. Total turnover equalled EUR 12.1m (-6.3% y-o-y) and EBITDA, EBIT and net income were 32.2%-161.3% below last year. Like in Q1/23, there were no asset sales. At the end of March 2024, WXF had net debt of EUR 212.5m (31/12/23: EUR 210.3m, 31/03/23: EUR 218.1m).

While the Chopin co-living/office building in Cracow and the MC55 in Bialystok have already received the building permits, we still expect that they will only be completed in 2027E as WXF makes the start of construction dependent on market conditions. In April 2024, Warimpex received the BREEAM certificate for the 4th building: the Red Tower in Lodz. This shows that sustainability and conformity with EU Taxonomy are clearly in the management’s focus.

You can download the research here:
http://www.more-ir.de/d/29983.pdf
For additional information visit our website https://eastvalueresearch.com/.

Contact for questions
Adrian Kowollik
Email: ak@eastvalueresearch.com
Tel. +49 30 20609082

-------------------transmitted by EQS Group AG.-------------------

The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

Visual performance / price development - Warimpex Finanz- und Beteiligungs AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.